Shopping Cart 0
Cart Subtotal
AED 0

Axonics Modulation Technologies Inc (AXNX) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Axonics Modulation Technologies Inc (Axonics) is an independent medical device company that develops and commercializes implantable neuromodulation technology for the treatment of urinary and bowel dysfunction. The company's Sacral Neuromodulation System (r-SNM) is designed for the treatment of overactive bladder, fecal incontinence, and urinary retention. The Axonics r-SNM system comprises a temporary disposable external trial system and implantable components such as a miniaturized rechargeable implantable stimulator, a universal remote control and an intuitive clinician programmer which facilitates the lead placement procedure and programming, tined lead, and patient-friendly items including charging system optimized for reduced charge time with no heating. Axonics is headquartered in Irvine, California, the US.

Axonics Modulation Technologies Inc (AXNX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Axonics Modulation Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Axonics Modulation Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Axonics Modulation Technologies Inc, Medical Equipment, Deal Details 10

Venture Financing 10

Axonics Modulation Technologies Raises Additional USD20.5 Million in Series C Financing 10

Axonics Modulation Technologies Raises USD14.5 Million in Series C Financing 11

Axonics Modulation Technologies Raises USD38.5 Million in Series B Financing Round 13

Axonics Modulation Raises USD17.3 Million in Venture Financing 15

Axonics Modulation Technologies Raises USD 32.6 Million In Series A Financing 16

Private Equity 18

Axonics Modulation Raises USD20.1 Million in Equity Financing 18

Axonics Modulation Technologies Inc-Key Competitors 19

Axonics Modulation Technologies Inc-Key Employees 20

Axonics Modulation Technologies Inc-Locations And Subsidiaries 21

Head Office 21

Recent Developments 22

Corporate Communications 22

Sep 06, 2017: Axonics Appoints Dr. Karen L. Noblett as Chief Medical Officer 22

Product News 23

Nov 15, 2018: Axonics granted Seven U.S. Utility Patents related to its Implantable Sacral Neuromodulation technology 23

Dec 04, 2017: Axonics Granted Seven New U.S. Patents Related to Its Implantable Sacral Neuromodulation Technology 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Axonics Modulation Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Axonics Modulation Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Axonics Modulation Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Axonics Modulation Technologies Inc, Medical Equipment, Key Facts 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Axonics Modulation Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Axonics Modulation Technologies Inc, Deals By Market, 2012 to YTD 2018 8

Axonics Modulation Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Axonics Modulation Technologies Raises Additional USD20.5 Million in Series C Financing 10

Axonics Modulation Technologies Raises USD14.5 Million in Series C Financing 11

Axonics Modulation Technologies Raises USD38.5 Million in Series B Financing Round 13

Axonics Modulation Raises USD17.3 Million in Venture Financing 15

Axonics Modulation Technologies Raises USD 32.6 Million In Series A Financing 16

Axonics Modulation Raises USD20.1 Million in Equity Financing 18

Axonics Modulation Technologies Inc, Key Competitors 19

Axonics Modulation Technologies Inc, Key Employees 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Axonics Modulation Technologies Inc , Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Axonics Modulation Technologies Inc (Axonics) is an independent medical device company that develops and commercializes implantable neuromodulation technology for the treatment of urinary and bowel dysfunction. The company's Sacral Neuromodulation System (r-SNM) is designed for the treatment of overactive bladder, fecal incontinence, and urinary retention. The Axonics r-SNM system comprises a temporary disposable external trial system and implantable components such as a miniaturized rechargeable implantable stimulator, a universal remote control and an intuitive clinician programmer which facilitates the lead placement procedure and programming, tined lead, and patient-friendly items including charging system optimized for reduced charge time with no heating. Axonics is headquartered in Irvine, California, the US.

Axonics Modulation Technologies Inc (AXNX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Axonics Modulation Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Axonics Modulation Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Axonics Modulation Technologies Inc, Medical Equipment, Deal Details 10

Venture Financing 10

Axonics Modulation Technologies Raises Additional USD20.5 Million in Series C Financing 10

Axonics Modulation Technologies Raises USD14.5 Million in Series C Financing 11

Axonics Modulation Technologies Raises USD38.5 Million in Series B Financing Round 13

Axonics Modulation Raises USD17.3 Million in Venture Financing 15

Axonics Modulation Technologies Raises USD 32.6 Million In Series A Financing 16

Private Equity 18

Axonics Modulation Raises USD20.1 Million in Equity Financing 18

Axonics Modulation Technologies Inc-Key Competitors 19

Axonics Modulation Technologies Inc-Key Employees 20

Axonics Modulation Technologies Inc-Locations And Subsidiaries 21

Head Office 21

Recent Developments 22

Corporate Communications 22

Sep 06, 2017: Axonics Appoints Dr. Karen L. Noblett as Chief Medical Officer 22

Product News 23

Nov 15, 2018: Axonics granted Seven U.S. Utility Patents related to its Implantable Sacral Neuromodulation technology 23

Dec 04, 2017: Axonics Granted Seven New U.S. Patents Related to Its Implantable Sacral Neuromodulation Technology 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

Axonics Modulation Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Axonics Modulation Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Axonics Modulation Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Axonics Modulation Technologies Inc, Medical Equipment, Key Facts 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Axonics Modulation Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Axonics Modulation Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Axonics Modulation Technologies Inc, Deals By Market, 2012 to YTD 2018 8

Axonics Modulation Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Axonics Modulation Technologies Raises Additional USD20.5 Million in Series C Financing 10

Axonics Modulation Technologies Raises USD14.5 Million in Series C Financing 11

Axonics Modulation Technologies Raises USD38.5 Million in Series B Financing Round 13

Axonics Modulation Raises USD17.3 Million in Venture Financing 15

Axonics Modulation Technologies Raises USD 32.6 Million In Series A Financing 16

Axonics Modulation Raises USD20.1 Million in Equity Financing 18

Axonics Modulation Technologies Inc, Key Competitors 19

Axonics Modulation Technologies Inc, Key Employees 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Axonics Modulation Technologies Inc , Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.